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Abstract
Background Obesity surgery involves mechanical and physi-
ological changes of the gastrointestinal tract that might pro-
mote colorectal cancer progression. Thus, we hypothesised
that obesity surgery is associated with poorer prognosis in
patients with colorectal cancer.
Methods This nationwide population-based cohort study in-
cluded all patients with an obesity diagnosis who subsequent-
ly developed colorectal cancer in Sweden from 1980 to 2012.
The exposure was obesity surgery, and the main and second-
ary outcomes were disease-specific mortality and all-cause
mortality, respectively. Cox proportional hazard survival
models were used to calculate hazard ratios (HRs) with 95%
confidence intervals (CIs), adjusted for sex, age, calendar year
and education level.
Results The exposed and unexposed cohort included 131 obe-
sity surgery and 1332 non-obesity surgery patients with colo-
rectal cancer. There was a statistically significant increased
rate of colorectal cancer deaths following obesity surgery (dis-
ease-specific HR 1.50, 95% CI 1.00–2.19). When analysed
separately, the mortality rate was more than threefold in-
creased in rectal cancer patients with prior obesity surgery
(disease-specific HR 3.70, 95% CI 2.00–6.90), while no in-
creased mortality rate was found in colon cancer patients (dis-
ease-specific HR 1.10, 85% CI 0.67–1.70).
Conclusion This population-based study among obese indi-
viduals found a poorer prognosis in colorectal cancer follow-
ing obesity surgery, which was primarily driven by the higher
mortality rate in rectal cancer.
Keywords Bariatric surgery . Colorectal neoplasms .
Mortality . Survival . Registry
Introduction
Obesity is associated with increased incidence and de-
creased survival in several malignancies, including colorec-
tal cancer [1, 2]. Some studies have also shown an overall
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decreased risk of obesity-related cancer following obesity sur-
gery [3–6], with the exception of colorectal cancer for which
an increased risk has been identified [7, 8]. However, the
potential effect of obesity surgery on colorectal cancer prog-
nosis has not been studied previously. As obesity plays a neg-
ative role in overall cancer diagnostics and treatment [9],
weight loss through obesity surgery might have a favourable
impact on prognosis. Typically, obesity surgery patients also
have more encounters with healthcare that might increase the
chance of early cancer detection. However, obesity surgery
could have a negative impact on colorectal cancer prognosis.
Symptoms caused by a colorectal tumour might be confused
with symptoms associated with obesity surgery, such as
weight loss, altered bowel habits and abdominal pain, which
might delay diagnosis. Furthermore, obesity surgery involves
major anatomical and physiological changes of the gastroin-
testinal tract that might promote malignant transformation of
the colorectal mucosa [10]. For example, hyperproliferation of
the rectal mucosa has been observed among patients undergo-
ing obesity surgery by means of gastric bypass, which could
indicate more aggressive tumour growth [11]. The aim of this
study was to elucidate the association between obesity surgery
and colorectal cancer prognosis, and we hypothesised that
obesity surgery worsens the prognosis for patients with colo-
rectal tumours.
Methods
Study Design
This was a nationwide, population-based cohort study in-
cluding all patients with a hospital discharge diagnosis of
obesity in the Swedish Patient Registry combined with a
diagnosis of colorectal cancer in the Swedish Cancer
Registry from 1st of January 1980 to 31st of December
2012. The Swedish Patient Registry holds information on
hospital discharges in Sweden, including admission and dis-
charge dates, main- and co-diagnoses and surgical proce-
dures. This register was 85% nationally complete between
1980 and 1986 and has been 100% complete since 1987
[12]. The registration of surgical procedure codes in the
Patient Registry is >95% accurate and >98% complete
[13]. The Cancer Registry records cancer cases in Sweden
since 1958; it has an overall completeness of 98%, and 99%
of the tumours are morphologically verified [14]. The regis-
ters can be linked by means of the unique 10-digit personal
identity numbers assigned to all Swedish residents upon
birth or immigration [15]. The study was approved by the
Regional Ethical Review Board in Stockholm, Sweden (ref-
erence number 2012/210-31/2). No informed consent from
participants is required for register-based studies according
to Swedish law.
Study Cohort
Eligible cohort members were identified from diagnosis codes
in the registers: obesity was identified from the codes 287,
277, 278A and E66 in the International Classification of
Disease (ICD) versions 8 to 10 in the Patient Registry, and
colorectal cancer was detected from the diagnosis codes 153-
154 in ICD7 (corresponding to C18-C20 in ICDO3) in the
Cancer Registry. Only patients with colorectal cancer as their
first cancer and who received this diagnosis after the date of
obesity diagnosis or date of obesity surgery were included in
the study. The cohort of obese study participants was grouped
into those who had undergone obesity surgery (exposed) and
those who had not (unexposed). Obesity surgery was
ascertained from surgical codes in the Patient Register:
4750-4754 before 1997, and JFD00-01, JDF10-11, JDF20-
21 and JFD00 from 1997 and onwards according to the
NOMESCO Classification of Surgical Procedures.
Follow-Up
The main study outcome was colorectal cancer-specific sur-
vival, measured through disease-specific deaths, and the sec-
ondary outcome was overall survival, measured through all-
cause deaths. Dates and causes of death were ascertained
through record linkage based on the personal identity numbers
from the Swedish Causes of Death Registry. Colorectal
cancer-specific deaths were identified through the diagnosis
codes 153-154 in ICD 8-9 and C18-C20 in ICD 10. The
Causes of Death Registry has nationwide coverage since
1961. Causes of death are reported by the physician issuing
the death certificate; ≤1% of the cases lack cause of death data,
and the registration of death dates is 100% complete [16].
Migration data were retrieved from the Swedish Registry of
the Total Population, and study participants that emigrated
during the study period were censored. Data on highest
achieved education level were retrieved from the Swedish
Education Registry, and were collected to adjust for potential
confounding by education. The Registry of the Total
Population is updated continuously and the Education
Register is updated yearly [17].
Statistical Analysis
Cox proportional hazard models were used to calculate
hazard ratio (HR) with 95% confidence intervals (CI) for
disease-specific and all-cause mortality, comparing obese
cohort members with and without a history of obesity
surgery prior to their colorectal cancer diagnosis. The anal-
yses were performed for colon and rectal cancer patients
combined as well as separately. Time to event was defined
as the time elapsed from the date of colorectal cancer di-
agnosis until the first occurrence of any of the following
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events: death, emigration or end of follow-up (December
31, 2012). In multivariate modelling, HRs were adjusted
for the following potential confounders: sex, age at diag-
nosis (continuous), calendar period (categorised into
1980–1999 and 2000–2012) and education level
(categorised into low [≤9 years], medium [10–12 years]
and high [>12 years] based on the Swedish schooling sys-
tem). We included an interaction term between surgery and
tumour location (colon or rectum) to assess differences in
HR between tumour sites and evaluated significance with
the likelihood ratio test. Model assumptions and fit were
assessed formally and graphically. A penalized spline for
age was introduced in the colon cancer subgroup analysis
in order to satisfy the proportional hazard assumption [18];
smoothing parameters were selected based on the Akaike
information criterion [19]. In a separate analysis, we
modelled obesity surgery as a categorical variable with
four possible values (no surgery, gastric bypass, restrictive
procedures [gastr ic banding and vert ical banded
gastroplasty] and malabsorptive procedures) to evaluate
whether the type of obesity procedure affects colorectal
cancer prognosis differently.
Because information on education level was missing for
4% of the patients, we used multiple imputations by chained
equations under a missing at random assumption for this var-
iable in the multivariate model [20]. Sensitivity analysis with a
complete-case analysis under the missing completely at ran-
dom assumption, and multiple imputations under the missing-
not-at-random assumption yielded similar results [21]. All sta-
tistical tests were two-sided, and results were considered sig-
nificant at a 5% significance level. The statistical software R
was used for all statistical analyses [22].
Results
Study Participants
The study cohort consisted of 1463 patients with an obe-
sity diagnosis followed by a colorectal cancer diagnosis
during the study period. Among these patients, 1009 had
colon cancer (69%), 449 had rectal cancer (31%) and 5
had both colon and rectal cancer codes. Altogether, 131
(9%) had undergone obesity surgery, while the remaining
Fig. 1 Flowchart for inclusion
and exclusion of patients with
diagnoses of colorectal cancer
and obesity in Sweden from 1980
to 2012, according to obesity
surgery status
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1332 patients had not. A flowchart describing the inclu-
sion and exclusion of patients is presented in Fig. 1.
Characteristics of the obesity surgery and non-obesity sur-
gery cohort members are presented in Table 1. The obe-
sity surgery group was younger and included more women
than the non-obesity surgery group, while diabetes and
cardiovascular diseases were more common in non-
obesity surgery patients.
Out of 45 (34%) patients in the obesity surgery cohort
that died during the study period, 32 (24%) died from
colorectal cancer. The number of deaths among the non-
obesity surgery cohort members was 596 (45%), of whom
354 (27%) died from colorectal cancer. The median length
of follow-up was 3.7 years among obesity surgery and
4.3 years among non-obesity surgery participants. The sur-
vival proportions are presented in Fig. 2. Most patients
Table 1 Characteristics of
patients with a diagnosis of
colorectal cancer and obesity,
who had or had not undergone
obesity surgery, between 1980
and 2012 in Sweden
No obesity surgery
(n = 1332)
Number (%)
Obesity surgery
(n = 131)
Number (%)
Age at colorectal cancer diagnosis, years
<56 240 (18) 62 (47)
≥56 1092 (82) 69 (53)
Sex
Male 679 (51) 40 (31)
Female 653 (49) 91 (69)
Year of colorectal cancer diagnosis
1980–1999 413 (31) 30 (23)
2000–2012 919 (69) 101 (77)
Obesity surgery procedure
Gastric bypass – 34 (26)a
Gastric banding – 43 (33)a
Vertical banded gastroplasty – 47 (36)a
Malabsorptive surgery – 7 (5)a
Education
Low (≤9 years) 634 (48) 46 (35)
Medium (10–12 years) 460 (35) 61 (47)
High (>12 years) 183 (14) 18 (14)
Missing 55 (4) 6 (5)
Comorbidity
Diabetes 427 (32) 29 (22)
Cardiovascular disease 289 (22) 13 (10)
Hypertension 481 (36) 39 (30)
Chronic obstructive pulmonary disease 120 (9) 8 (6)
Colorectal cancer 1332b 131b
Colon cancer 917 (69) 97 (74)
Rectal cancer 419 (31) 35 (26)
Tumour stage (TNM)c
0–I 192 (14) 16 (12)
II–III 304 (23) 32 (24)
IV 107 (8) 19 (15)
Unknown 729 (55) 64 (49)
a One patient in the obesity surgery cohort was coded with gastric bypass and non-gastric bypass surgery
simultaneously.
b One patient in the obesity surgery cohort and four patients in the non-obesity surgery cohort were diagnosed with
colon and rectal cancer simultaneously.
c Patients for whom data on tumour stage were available. Data on tumour stage were only available in patients
diagnosed from 2004 and onward
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with colorectal cancer as the cause of death died within the
first 5 years of diagnosis.
Colorectal Cancer Survival
Colorectal cancer patients who had undergone prior obesity
surgery experienced higher cancer-specific (HR 1.50; 95% CI
1.00–2.19) and overall mortality rates (HR 1.62; 95% CI 1.18
to 2.22) than patients without such surgery (Table 2). Separate
analyses of colon and rectal cancer patients revealed no sig-
nificant difference in mortality rates between obesity surgery
and non-obesity surgery patients with respect to colon cancer
(disease-specific HR 1.10; 95% CI 0.67–1.70). However,
cancer-specific deaths in rectal cancer patients were threefold
higher in those who had undergone previous obesity surgery
compared to those who had not (disease-specific HR 3.70;
95% CI 2.00–6.90). Overall survival mirrored the disease-
specific survival (Table 2). In a separate analysis, obesity sur-
gery was categorized according to type of procedure. The
results showed borderline significant association between co-
lorectal cancer-specific mortality and restrictive procedures
(HR 1.49; 95% CI 1.00–2.22) and no significant association
with gastric bypass or malabsorptive procedures.
Discussion
This study indicates that among obese individuals diagnosed
with colorectal cancer, previous obesity surgery had a nega-
tive prognostic impact on cancer survival that was primarily
driven by the threefold higher rates of cancer deaths in patients
with rectal cancer.
Colorectal cancer is the only known malignancy where the
risk of being diagnosed with the disease seems to increase
after obesity surgery [7, 8]. The present study suggests that
this increase translates into poorer survival in rectal cancer but
not colon cancer when compared to obese controls.
Differences in aetiology and biological mechanisms between
colon and rectal cancer might explain the divergent findings
between the tumour sites [23]. The somatic mutation profile is
similar between colon and rectal tumours, but there are differ-
ences in phenotype and effect modifiers [24–26]; it is, e.g.
recognised that obesity is a stronger risk factor for colon can-
cer than rectal cancer [2, 27, 28]. Furthermore, colon and
rectal cancers face different treatment regimens. Pre-
operative radiotherapy is for example used in rectal cancer
but not in colon cancer. We cannot exclude that other
Fig. 2 Disease-specific survival proportion of patients with obesity and
colon or rectal cancer in Sweden from 1980 to 2012, according to obesity
surgery status
Table 2 Obesity surgery and all-cause or disease-specific death among obese patients with colorectal cancer, presented as hazard ratio (HR) and 95%
confidence interval (CI)
Mortality No. of patients,
surgery
No. of patients,
no surgery
Unadjusted
HR
95% CI P value Adjusted HRa 95% CI P value
Colorectal cancer
Disease-specific deaths 32 354 1.09 0.76 to 1.6 0.64 1.50 1.00 to 2.19 0.04
All deaths 45 596 1.30 0.96 to 1.8 0.09 1.62 1.18 to 2.22 <0.001
Colon cancer
Disease-specific deaths 20b 251 0.71 0.45 to 1.10 0.14 1.10 0.67 to 1.70 0.75
All deaths 29 419b 0.60 0.41 to 0.87 0.0078 1.28 0.87 to 1.90 0.21
Rectal cancer
Disease-specific deaths 13b 103 1.80 1.00 to 3.30 0.038 3.70 2.00 to 6.90 <0.0001
All deaths 16 177b 1.60 0.97 to 2.60 0.064 3.00 1.80 to 5.10 <0.0001
aAdjusted for sex, age at diagnosis, year of diagnosis, and education. Missing data on education (4%) was imputed under the missing-at-random
assumption
bOne patient in the obesity surgery cohort was diagnosed with both colon and rectal cancer simultaneously and died of rectal cancer; four patients in the
non-obesity surgery cohort were diagnosed with both colon and rectal cancer simultaneously, and two patients died of other causes than colorectal cancer
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confounding factors, e.g. changes in lifestyle factors, may
have contributed to the worse prognosis in rectal cancer fol-
lowing bariatric surgery. However, any such confounding
should be similar for colon cancer. Moreover, it is likely that
lifestyle habits changed to more healthy behaviours and in-
creased health awareness following obesity surgery.
A study of patients undergoing gastric bypass for obesity
found hyperproliferation of the rectal mucosa as a result of
increased expression of proinflammatory genes from6months
up to 3 years after surgery [11], indicating potentially more
aggressive tumour growth. Our study could, however, not
confirm if type of bariatric procedure had an impact on colo-
rectal cancer prognosis. Most of the patients in the cohort had
undergone restrictive obesity surgery (69%), and the sample
size was not sufficiently powered to evaluate the association
between specific types of bariatric procedure and colorectal
cancer-specific deaths.
The overall higher rate of deaths observed in obesity sur-
gery patients in this study contradicts previous findings that
obesity surgery is protective of mortality. However, our anal-
yses are limited to patients with colorectal cancer, and a ma-
jority of these patients succumbed to their cancer (71%). Thus,
findings from the all-cause mortality analysis were mainly
influenced by disease-specific mortality.
Strengths of this study include the population-based co-
hort design including all patients with colorectal cancer and
obesity diagnosis from nationwide Swedish registers that
reduces selection bias and increases generalisability of the
results. The high validity of the registers from which data
on study exposure and outcomes were obtained decreases
the risk of information bias. However, a limitation is that
only patients with a recorded diagnosis of obesity were
included, which possibly excludes obese patients who are
otherwise healthy. The results were adjusted for several
confounding factors, but we lacked information on other
potential confounders including body mass index. As there
have been large changes in treatment options during the
long study period, we adjusted for calendar period to ac-
count for this variation. Tumour stage is commonly adjust-
ed for in cancer survival studies; however, as obesity sur-
gery might lead to altered pathophysiology, tumour stage
could be a mediator in the causal pathway between obesity
surgery and colorectal cancer prognosis and were thus not
adjusted for in this study. We searched for colorectal cancer
deaths in both underlying and contributing causes of death.
Whether this inclusion overestimates the number of colo-
rectal cancer deaths is unknown, but there is no reason to
believe that any such misclassification would be differential
between obesity surgery patients and obese controls. Non-
differential misclassification of outcome would only dilute
associations, and thus not explain the increased mortality in
rectal cancer [29]. Finally, we cannot exclude that the find-
ings in the present study are due to chance, in spite of the
strong and statistically significant association between obe-
sity surgery and rectal cancer.
In conclusion, this nationwide, Swedish cohort study with
long and complete follow-up found increased mortality from
rectal cancer, but not from colon cancer, following obesity
surgery. Since this is the first study addressing this question,
more research is needed before a definite association can be
concluded. If the association is true, clinicians should be made
aware of the increased risk and poorer prognosis of rectal
cancer in patients with prior obesity surgery.
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